The long-term administration of erythromycin (EM), clarithromycin (CAM) or azithromycin (AZM) has generally resulted in a favorable outcome for patients with diffuse panbronchiolitis (DPB) infected with mucoid Pseudomonas aeruginosa. To elucidate the mechanism involved, the influence of macrolides on mucoid alginate production by k? aeruginosa was investigated in vitro.
INTRODUCTION
It is well known that the bacteria that colonize mucous membranes or medical devices in nutrient-poor conditions often produce mucoid alginate (glycocalyx) around their bodies and form a bacterial biofilm [ 1-31. In this state, the biofilm bacteria are usually resistant to attack by antimicrobial agents [4-61 and host phagocytes [7, 8] . Cystic fibrosis (CF) [9, 10] and diffuse panbronchiolitis (DYB) [I I] are typical diseases that show bacterial biofilm formation by the niucoid alginate produced by Pseudomonas aeruginosa [12, 13] . In 1987, the 10-year survival rate of DPB patients in Japan was only 12.4% for those colonized with mucoid I? aeruginosa but 73.1% for those without I? aeruginosa [14] . In the past 10 years, however, long-term administration of erythromycin (EM) [15] , clarithromycin (CAM) [16] or azithromycin (AZM) [17] as basic therapy has been used, and the prognosis of patients, including that of patients colonized with I! aeruginosa, has improved remarkably, reaching a 10-year survival rate of over 90%. This clinical efficacy of macrolides was not observed with 16-membered macrolides. O n the other hand, alginate facilitates bacterial adherence to lung tissue [18, 19] and plays a pathogenic role in some diseases which are associated with persistent colonization with mucoid J? aevuginosa [7, 8, 20] .
Against this background, the influence of macrolides on niucoid alginate production by J? aeruginosa was examined in vitro.
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METHODS
Materials
Mucoid I! aerclgrinosu PT-1578 (provided by Pfizer Pharmaceutical Inc., Tokyo), a niucoid clinical isolate, was used in this study. The strain was preincubated on heart infusion agar (Nissui Phariiiaceutical Co., Ltd, Tokyo) at 37°C. EM (Dainippon Pharmaceutical Co., Ltd, Osaka), AZM (Pfizer Pharmaceutical Inc.), niidecariiycin (MDM) (Meiji Seika Kaisha, Ltd., Tokyo) and CP-4305 (Meiji Seika Kaisha, Ltd, Tokyo) were used ( Figure 1 ). All agents were dissolved in methanol, and methanol alone was used as the control in experiments.
Determination of MlCs
The minimum inhibitory concentrations (MICs) for the strain of each inacrolide were measured on Mueller-Hinton agar by the twofold dilution method. The inoculum was lo6 colony-forming units (CFU) per spot.
In vitro formation of biofilm on membrane filters and effect of macrolides I! nevclgirzosa PT-1578 was suspended in biological saline (saline) to 10* CFU/mL, and 50 yL was put on polycarbonate membrane filters with a pore size of 0.22 pin (Nihon Millipore Kogyo K. K., Tokyo) which were set on saline agar. Each membrane filter was incubated a t 37 "C for 5 days. After confirmation of the presence of the bacterial biofilm by scanning electron microscopy, the menibrane filters were transferred into 2 niL of 20% alginate-promoting (AP) medium 121 1 (100 mM monosodium glutamate, 100 iiiM sodium gluconate, 7.5 mM NaH2PO4, 16.3 m M KzHPO4, 10 mM MgS04.7H20) including 10 pg/mL of each macrolide, and then incubated at 37°C for 5 days.
Quantitative analysis of alginate
After suspending I! aerqinosa PT-1578 in saline to lo2 CFU/mL, 100 yL of the solution was put on polycarbonate membrane filters with a pore size of 0.22 pin (Millipore) set on 10% AP medium agar including each macrolide (final concentrations: 1 and 10 yg/~iiL). Each membrane filter was incubated at 37OC for 27 h, and then left at room temperature for 18 h. The membrane filter with bacteria colonizing its surfaces was put into 2 m L of saline and vigorously stirred for 1 min. To remove the bacterial bodies, the sample obtained by the above method was centrifuged at 7000g for 10 min. The supernatant was extracted and used for the determination of alginate.
Quantitative analysis of alginate was performed by the Bitter-Muir method [22] . The sample in 0.5 mL was gently added to 2 niL of 0.95% Na2B407.10HzO in 98% H2S04 in an ice bath, and, after mixing, the mixture was heated at 100°C for 10 min and cooled in an ice bath. After stirring with 0.1 mL of 0.125% carbazole in ethanol, the mixture was heated at 100°C for 15 min again. When the mixture was cooled in an ice bath to room temperature, the optical density was measured at 530 nni with a spectrophotometer (model 100-60; Hitachi-Seisakusho, Tokyo). The quantity of alginate was calculated on the basis of a standard curve made with D( +)-glucuronolactone.
Data were from triplicate determinations and were expressed as means and the standard deviation.
Purification of guanosine diphospho-0-mannose dehydrogenase
Bacterial cells were grown aerobically in 500 mL of AP medium a t 37°C for 18 h. The culture was used to inoculate 6.5 L of AP medium, and cells were then grown aerobically at 37°C for 5 h. The cells were harvested by centrifugation at 10 000g at 4°C for 30 min. Approximately 6 g wet weight of the cell pellet was washed once with 200 mL of Dulbecco's phosphate-buffered saline (PBS) (Gibco Laboratories, Grand Island, NY) and resuspended in 10 mL of sonication buffer containing 10 mM 3-(N-morpholinopropanesulfonic acid) (MOPS), 0.5 niM phenylniethylsulfonyl fluoride (PMSF) and 2 m M dithiothreitol (DTT) a t pH 7.0. The cells were disrupted by ultrasonic disruptor model UR-200P (Tomy Seikou Co., Ltd, Tokyo). Cell debris was removed by centrifugation at 20 000g at 4°C for 1 h. This supernatant was treated with protamine sulfate to a 1% final concentration and immediately centrifuged at 20 000g at 4°C for 1 h to remove DNA. The final supernatant was filtered with a membrane filter ofpore size 0.45 pm (Toyo Roshi Kaisha, Ltd, Tokyo) and then dialyzed against 500 mL of elution buffer containing 50 mM Tris-HC1, 1 mh4 PMSF and 5 mM D T T at pH 7.5 at 4°C overnight. The crude extract was applied to an elution buffer-equilibrated DEAE TOYOPAL 650s (Tosoh Ltd, Tokyo) column (1 x 10 cm) and fractionated by elution with a 0-0.2 M linear gradient of NaCl in elution buffer.
Effects of macrolides on guanosine diphospho-0-mannose dehydrogenase activity
GDP-mannose dehydrogenase activity was measured by Preiss's method [23] . That is, the enzymatic activity of GDP-mannose dehydrogenase was assayed by optical density at 340 mi at 30 "C using a spectrophotometer. A GDP-inannose dehydrogenase fraction sample of 50 pL was obtained from a total volume of 500 pL of substrate solution containing 50 mM Tris-HC1, 10 niM MgCL, 1 mM NAD and 1 mM GDP-D-mannose at pH 7.5. N o endogenous dehydrogenase activity was detected in the GDP-mannose dehydrogenase fraction sample, as indicated by the absence of reduction of NAD when GDP-mannose was omitted from the incubation mixture. One unit of enzymatic activity was defined as that which reduced 1 pmol of NAD per niin under the specified conditions.
The interaction between GDP-mannose dehydrogenase activity and niacrolides was investigated by the following methods. Macrolides dissolved in methanol were added to the GDP-mannose dehydrogenase fraction saniple and it was incubated at 30OC for 5 min. At a 0.25-1.5 niM final concentration of macrolides, GDP-mannose dehydrogenase activity was measured in comparison with methanol solution as the control.
Statistical analysis
Student's t-test was used for statistical analysis of data.
The niacrolides used in this study were EM with a 14-membered ring, AZM with a 15-membered ring, MDM with a 16-membered ring, and CP-4305, a derivative of MDM ( Figure I ). In CP-4305, which has had inycarose removed from MDM, mycaminose appears on the surface. In EM and AZM, desosaminose, which is similar to inycaminose, occurs on the surface. From this point of view, CP-4305 is similar to EM and AZM. These niacrolides were chosen to analyze the mechanism of action against I? nerugitzosa biofilni.
MlCs of macrolides for bacteria
The MICs of EM, AZM, CP-4305 and MDM for F! aeruginasa PT-1578 were 50, 200, >400 and >400 pg/mL, respectively.
Effects of macrolides on the structure of biofilm
The biofilm model of P aeruginosa PT-1578 on the surfaces of membrane filters was observed by scanning electron microscopy after 5 days of treatment with 10 pg of inacrolides per mL (Figure 2 ). In the control, membranous structures covering the colonies with glycocalyx were preserved for 5 days (a). After incubation with 10 pg/mL EM (b), AZM (c) and CP-4305 (d), reduction of the glycocalyx and eradication of the nieinbranous structures were observed. However, neither the significant decrease in glycocalyx N a g i n o a n d K o b a y a s h i : I n f l u e n c e o f r n a c r o l i d e s o n a l g i n a t e 4 3 5 nor eradication of the membranous structure was observed after incubation with 10 pg/iiiL MDM (e).
Effects of macrolides on alginate productian
Alginate production by lo8 CFU of I? ueruginosa is shown quantitatively (Figure 3 ) . Compared with the control, the production of alginate was inhibited by incubation with EM, AZM and CP-4305 in a dosedependent manner, but no inhibitory effect was observed with MDM. Thus, the production of alh' m a t e was inhibited only by the Agents that exerted a deleterious effect on biofilm. elution profile of GDP-mannose dehydrogenase following fractionation is shown in Figure 4 . GDP-mannose dehydrogenase activity was detected as the only peak; no other peaks were detected. The GDP-mannose dehydrogenase fractions were used to investigate the effect of macrolides o n GDP-mannose dehydrogenase activity.
GDP-mannose dehydrogenase activities in the controls were AOD 0.538 and AOD 0.514. The value of the control was assumed to be loo%, and each value was compared with this. After the enzyme and the macrolides had been incubated at 30OC for 5 niin, 500 mL of the substrate solution was added. A dosedependent reduction in GDP-mannose dehydrogenase activity was observed after incubation with EM, AZM and CP-4305, but not M D M ( Figure 5 ). CP-4305 was the most potent inhibitor of the three agents, followed by AZM.
Biofilm bacteria usually show resistance to antimicrobial Effects of macrolides on GDP-mannose dehydrogenase agents, but the killing of l? aeruginosa inside biofdm was activity obtained by the combined use of ciprofloxacin (CPFX) The cells were disrupted by sonic vibration, and and CAM [11, 24] or AZM [11, 24] rather than by the supernatant was obtained by centrifugation. GDP-CPFX alone. This was also observed with EM, but niannose dehydrogenase was separated by anion not with josaniycin [25] . A possible interpretation exchange Chromatography from this supernatant. The is that 14-or 15-membered niacrolides facilitate the penetration of the bacterial biofilm by CPFX, which would then eliminate the bacteria inside the biofilm. Thus, the anti-P aevuginosa action of CPFX and the anti-alginate action of such macrolides depend on their combined effects. In this investigation, incubation of P aeruginosa biofilnis with EM, AZM and (3-4305 for 5 days resulted in destruction of biofilni substance, but this did not occur with MDM. The findings indicate that such macrolides express some sort of anti-alginate action, even if they have no ability to kill P aevuginosa.
The important point that we wish to emphasize is that the anti-alginate action of macrolides is a key point in understanding the mechanism of clinical efficacy seen in patients with DPB and other airway biofilm diseases, and probably in patients with CF, because the immune reaction induced by mucoid alginate plays an important role in the pathogenesis and clinical manifestations of DPB [26] and CF [27-291. In this paper, the 14-membered macrolide EM as well as the 15-membered macrolide AZM inhibited alginate production by mucoid P aevugiaosa in a dose-dependent manner, but no inhibitory effect was observed with the 16-membered macrolide MDM. The alginate biosynthetic pathway in mucoid J? aevuginosa has been demonstrated to involve phosphomannose isomerase (PMI) [30, 31] , phosphomannomutase (PMM) [30, 31] , guanosine diphospho-D-mannose pyrophosphorylase (GMP) [30, 31] , GDP-mannose dehydrogenase [30J 11, epimerase [32, 33] , polymerase [34] and acetylase [35] (Figure 6 ). The first four enzymes (PMI, PMM, GMP and GDPmannose dehydrogenase) of alginate biosynthesis are detected in mucoid I! aeruginosa but not in the non-mucoid form [36] . The enzymatic activity of GDP-niannose dehydrogenase is significantly higher than that of other enzymes in mucoid strains [37] . GDP-mannose dehydrogenase encoded by the ulgD gene is thought to be especially important in the alginate biosynthetic pathway.
EM and AZM inhibited the enzymatic activity of GDP-mannose dehydrogenase in a dose-dependent manner, but this inhibition was not observed with the 36-membered MDM. This may help to clarify the characteristics of 14-and 15-membered macrolides. In this study, the anti-GDP-mannose dehydrogenase effect began to appear at a concentration of 0.5 mM (EM, 367 pg/niL; AZM, 393 pg/mL; MDM, 407 pg/mL; (2-4305, 306 pg/mL) of macrolides. The concentration was unexpectedly higher than that indicated by clinical experience. O n the other hand, the enzymatic activity of GDP-mannose dehydrogenase in a single bacterium, even of a mucoid strain, is below the limit of detection. In crude enzyme from disrupted cells, 8 mL of cells in the stationary phase of growth was needed to detect the GDP-mannose dehydrogenase activity. This may be the reason why a higher concentration of macrolide was needed to show the inhibitory effect on GDP-niannose dehydrogenase activity in our experiments. No inhibition was observed at such a high concentration of MDM. In terms of clinical efficacy, a much lower dose of macrolide may be useful.
Another interesting result obtained in this study was that a similar inhibitory effect on both alginate production and GDP-mannose dehydrogenase activity was observed with CP-4305, which was derived by excising mycarose from the 16-membered macrolide MDM. The evidence indicates that the inhibitory effect could be seen when the terminal sugar was removed, with exposure of mycaminose, even in a 16-membered macrolide. This suggests that the inhibitory effect observed with 14-and 15-membered niacrolides is not based on the structural specificity of the macrolide ring per se, but depends on the sugar chain connected with position 5 of the ring, and that an adequate inhibitory effect can be obtained if the end sugar chain is removed, even in a 16-membered macrolide. Thus the efficacy of 14-and 15-membered macrolides in airway biofilm disease may depend on such structural factors.
